 |
Atezolizumab |
|---|---|
| Trade Name | Tecentriq� +Cotellic� |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-13 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS 35-5E;South San Francisco, California, 94080 |
| |
Atezolizumab |
|---|---|
| Trade Name | Tecentriq� +Cotellic� |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-13 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS 35-5E;South San Francisco, California, 94080 |